Concurrent celecoxib with 5-fluorouracil/epirubicin/cyclophosphamide followed by docetaxel for stages II-III invasive breast cancer: The OOTR-N001 study

Louis Wc Chow, Stewart Y. Tung, Ting Ying Ng, Seock Ah Im, Min Hyuk Lee, Adrian Ys Yip, Masakazu Toi, Stefan Glück

Research output: Contribution to journalArticle

15 Scopus citations

Fingerprint Dive into the research topics of 'Concurrent celecoxib with 5-fluorouracil/epirubicin/cyclophosphamide followed by docetaxel for stages II-III invasive breast cancer: The OOTR-N001 study'. Together they form a unique fingerprint.

Medicine & Life Sciences